Synthesis of silicon-substituted hydroxyapatite by a hydrothermal method with two different phosphorous sources

Silicon-substituted hydroxyapatite (Si-HA) with up to 1.8 wt% Si content was prepared successfully by a hydrothermal method, using Ca(NO₃)₂, (NH₄)₃PO₄ or (NH₄)₂HPO₄ and Si(OCH₂CH₃)₄ (TEOS) as starting materials. Silicon has been incorporated in hydroxyapatite (HA) lattice by partially replacing phosphate (PO₄³⁻) groups with silicate (SiO₄⁴⁻) groups resulting in Si-HA described as Ca₁₀(PO₄)_6−x(SiO₄)_x(OH)_2−x. X-ray diffraction (XRD), Fourier transform IR spectroscopy (FTIR), inductively coupled plasma AES (ICP-AES) and scanning electron microscopy (SEM) techniques reveal that the substitution of phosphate groups by silicate groups causes some OH⁻ loss to maintain the charge balance and changes the lattice parameters of HA. The crystal shape of Si-HA has not altered compared to silicon-free reference hydroxyapatite but Si-incorporation reduces the size of Si-HA crystallites. Based on in vitro tests, soaking the specimens in simulated body fluid (SBF), and MTT assays by human osteoblast-like cells, Si-substituted hydroxyapatite is more bioactive than pure hydroxyapatite.